CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

CVS Health CVS posted a strong third quarter, delivering a 47% year-over-year increase in adjusted earnings per share (EPS) to $1.60. Revenues reached a record $103 billion, up roughly 8% from last ...

CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter.

CVS Health (CVS) fell over 3% premarket on Wednesday even as the managed care giant exceeded Street forecasts with its third quarter 2025 results and raised its profit outlook for full year 2025 on ...

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees. David Rhew, ...

“The empirical evidence continues to support the attractive risk-return characteristics of CVs across the studies and ...

CVS Health Corp said on Wednesday it would administer Eli Lilly & Co's experimental antibody treatment to COVID-19 patients in their homes and in long-term care facilities through a U.S.

CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health ...